Terms: = Colorectal cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Clinical Outcome
807 results:
1. Development of a Novel Prognostic Panel for colorectal cancer Based on cancer Functional Status, and Validation of STC2 as a Promising Biomarker.
Liu X; Wei N; Chen H
Front Biosci (Landmark Ed); 2024 Jul; 29(7):245. PubMed ID: 39082333
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcomes in T4 and/or N2 Rectal cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study.
Unrau S; Barthwal M; Gurram L; Edward M; Hurton S; Kim C; Nashed M
Clin Colorectal Cancer; 2024 Sep; 23(3):251-257. PubMed ID: 38964940
[TBL] [Abstract] [Full Text] [Related]
3. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.
Nilsson E; Wetterholm E; Syk I; Thorlacius H; Rönnow CF
BJS Open; 2024 May; 8(3):. PubMed ID: 38869239
[TBL] [Abstract] [Full Text] [Related]
4. Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.
Cazeneuve N; Bouché O; Leger J; Borg C; Labbe-Devilliers C; Lucidarme O; Tasu JP; Manfredi S; Aubé C; Trillaud H; Manzoni P; Marcus C; Terrebonne E; Douillard JY; Chautard R; Lobet S; Scotto B; Bleuzen A; Lecomte T
Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102380. PubMed ID: 38788975
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Neoadjuvant Radiochemotherapy on Pathological Complete Response for Locally Advanced Rectal cancer: A Mono Institutional Experience.
Lucarelli M; Gentile V; Bonelli R; Pasquale G; Pizzi AD; Nicola MD; Porreca A; Genovesi D
In Vivo; 2024; 38(3):1367-1374. PubMed ID: 38688610
[TBL] [Abstract] [Full Text] [Related]
6. Spreading Through Air Spaces And Thinking About Lung Metastases.
M Castro P; Rei J; Silva C; Miranda J; Guerra M
Port J Card Thorac Vasc Surg; 2023 Oct; 30(3):31-35. PubMed ID: 38499034
[TBL] [Abstract] [Full Text] [Related]
7. Application Value of High-Quality Nursing in Operating Room in Rectal cancer Operation and its Influence on Postoperative Rehabilitation.
Liu J; Tan F; Zhang Y; Zhou P; Qian Q; He Q; Xu J
Surg Innov; 2024 Jun; 31(3):274-285. PubMed ID: 38468453
[TBL] [Abstract] [Full Text] [Related]
8. [clinical outcome of Five Patients with Perforated colorectal cancer].
Jinushi K; Ikenaga M; Odagiri K; Yanagimoto Y; Yamashita M; Takeyama H; Suzuki Y; Kawase T; Shimizu J; Imamura H; Dono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1566-1568. PubMed ID: 38303343
[TBL] [Abstract] [Full Text] [Related]
9. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
10. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
[TBL] [Abstract] [Full Text] [Related]
11. Transanal minimally invasive surgery for benign and malignant rectal lesions: midterm outcomes from a tertiary center.
Al-Dhaheri M; Al-Ishaq F; Toffaha A; Nada MA; Parvaiz A; Kurer M
Ann Saudi Med; 2023; 43(6):348-351. PubMed ID: 38071443
[TBL] [Abstract] [Full Text] [Related]
12. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717
[TBL] [Abstract] [Full Text] [Related]
13. Phase angle as a prognostic indicator of surgical outcomes in patients with gastrointestinal cancer.
Gulin J; Ipavic E; Mastnak DM; Brecelj E; Edhemovic I; Kozjek NR
Radiol Oncol; 2023 Dec; 57(4):524-529. PubMed ID: 38038415
[TBL] [Abstract] [Full Text] [Related]
14. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
[TBL] [Abstract] [Full Text] [Related]
15. Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes.
Siegelmann-Danieli N; Neiman V; Bareket-Samish A; Berger R; Peretz A; Alapi H; Tsur E; Patalon T; Beller D; Rimler G; Chodick G; Shohat M
Prostate; 2024 Jan; 84(1):39-46. PubMed ID: 37842866
[TBL] [Abstract] [Full Text] [Related]
16. Delayed-Onset Organ/Space Surgical Site Infection Worsens Prognosis in High-Risk Stage II and III colorectal cancer.
Okui J; Shigeta K; Kato Y; Mizuno S; Sugiura K; Seo Y; Nakadai J; Baba H; Kikuchi H; Hirata A; Makino A; Kondo T; Matsui S; Seishima R; Okabayashi K; Obara H; Sato Y; Kitagawa Y
J Gastrointest Surg; 2023 Nov; 27(11):2515-2525. PubMed ID: 37740145
[TBL] [Abstract] [Full Text] [Related]
17. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract] [Full Text] [Related]
18. Immune Marker Spatial Distribution and clinical outcome after PD-1 Blockade in Mismatch Repair-deficient, Advanced colorectal Carcinomas.
Saberzadeh-Ardestani B; Graham RP; McMahon S; Ahanonu E; Shi Q; Williams C; Hubbard A; Zhang W; Muranyi A; Yan D; Jin Z; Shanmugam K; Sinicrope FA
Clin Cancer Res; 2023 Oct; 29(20):4268-4277. PubMed ID: 37566222
[TBL] [Abstract] [Full Text] [Related]
19. Mesenchymal Stem Cells and Regenerative Therapy with Bilateral Gracilis Flaps for Perineal Reconstruction of a Wound Infection in the Setting of Anal Squamous Cell Carcinoma.
Garcia MF; Tiwari KK; Gendreau JL; Burgess PL; Taupin P; Martin ED
Adv Skin Wound Care; 2023 Aug; 36(8):1-7. PubMed ID: 37471451
[TBL] [Abstract] [Full Text] [Related]
20. Curative pelvic exenteration: initial experience and clinical outcome.
Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F
Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871
[TBL] [Abstract] [Full Text] [Related]
[Next]
